Back to Journals » Cancer Management and Research » Volume 13

Circ_0105346 Knockdown Inhibits Osteosarcoma Development via Regulating miR-1182/WNT7B Axis [Retraction]

Authors Liu J, Li X, Yue L, Lv H

Received 25 June 2021

Accepted for publication 25 June 2021

Published 30 June 2021 Volume 2021:13 Pages 5161—5162

DOI https://doi.org/10.2147/CMAR.S326513



Liu J, Li X, Yue L, Lv H. Cancer Manag Res. 2021;13:521–535.

The Editor and Publisher of Cancer Management and Research wish to retract the published paper. The authors initially requested the retraction claiming some results described in the initial study could not be repeated and there were concerns with the specificity of the β-actin primer used in the qRT-PCR assay. Despite several requests from the editorial office, the authors could not provide satisfactory raw data for their qRT-PCR assay. They were also unable to provide satisfactory raw data for the western blots described in the study. It was determined the findings of the study were invalid and the decision was made to retract the paper.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.